Surging Stock To Consider: Xtant Medical (NYSE: XTNT)

Booming healthcare stocks are surprising investors with millions of shares of their daily volumes. Around 10 biotech stocks popped at least by 20% and one of them is Xtant Medical (NYE: XTNT) that costs near $1.5 and tends to soar further as the revenue from new product Matriform Si for spinal fusion procedures may jump in Q3 and Q4.

Before cheap XTNT climbs over $2 some visionary traders may acquire in bulks, perhaps in millions until the market closes. On 1.64 million shares of Xtant is soaring via increasing the daily volume to, maybe, 3 million units.

Not many earnings making Xtant is surging this week as Friday was not a lucky trading day for 95,850 shares of daily volume.

Anthony Gonzales

Biotech, Tech, and Crypto reporterAnthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.